MY128351A - ß2-ADRENERGIC RECEPTOR AGONISTS - Google Patents

ß2-ADRENERGIC RECEPTOR AGONISTS

Info

Publication number
MY128351A
MY128351A MYPI9902273A MY128351A MY 128351 A MY128351 A MY 128351A MY PI9902273 A MYPI9902273 A MY PI9902273A MY 128351 A MY128351 A MY 128351A
Authority
MY
Malaysia
Prior art keywords
receptor agonists
adrenergic receptor
useful
treatment
bronchitis
Prior art date
Application number
Inventor
Edmund J Moran
Seok-Ki Choi
John H Griffin
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Priority to MYPI9902273 priority Critical patent/MY128351A/en
Publication of MY128351A publication Critical patent/MY128351A/en

Links

Abstract

DISCLOSED ARE MULTIBINDING COMPOUNDS WHICH ARE β2 ADRENERGIC RECEPTOR AGONISTS AND ARE USEFUL IN THE TREATMENT AND PREVENTION OF RESPIRATORY DISEASES SUCH AS ASTHMA. BRONCHITIS.THEY ARE ALSO USEFUL IN THE TREATMENT OF NERVOUS SYSTEM INJURY AND PREMATURE LABOR.MOST ILLUSTRATIVE DRAWING : (FIGURE 1)
MYPI9902273 1999-06-07 1999-06-07 ß2-ADRENERGIC RECEPTOR AGONISTS MY128351A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9902273 MY128351A (en) 1999-06-07 1999-06-07 ß2-ADRENERGIC RECEPTOR AGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9902273 MY128351A (en) 1999-06-07 1999-06-07 ß2-ADRENERGIC RECEPTOR AGONISTS

Publications (1)

Publication Number Publication Date
MY128351A true MY128351A (en) 2007-01-31

Family

ID=47278600

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9902273 MY128351A (en) 1999-06-07 1999-06-07 ß2-ADRENERGIC RECEPTOR AGONISTS

Country Status (1)

Country Link
MY (1) MY128351A (en)

Similar Documents

Publication Publication Date Title
AP1869A (en) b2- Adrenergic receptor agonists.
IL149317A0 (en) β2-ADRENERGIC RECEPTOR AGONISTS
YU42302A (en) Beta2-adrenergic receptor agonists
BG106762A (en) Polycycloalkylpurines as adenosine receptor antagonists
HK1074573A1 (en) Tetrahydroquinoline analogues as muscarinic agonists
MXPA04006280A (en) Spiroazacyclic compounds as monoamine receptor modulators.
HUP0600780A2 (en) Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
NZ329627A (en) 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones
NZ522326A (en) Adenosine A2A receptor antagonists
IL129592A0 (en) 5-HT1f agonists
HK1083838A1 (en) A2a adenosine receptor antagonists
BG105270A (en) Tetrahydropyridoethers
WO2004009559A3 (en) Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
IL141957A0 (en) 5ht1 receptor agonists and metoclopramide for the treatment of migraine
EP0835869A3 (en) New serotonin 5-HT1F agonists
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
MXPA02000680A (en) Vgf polypeptides and methods of treating vgf-related disorders.
MXPA02001204A (en) Calcilytic compounds.
MY128351A (en) ß2-ADRENERGIC RECEPTOR AGONISTS
IL135634A0 (en) 5-htif agonists
GB9805559D0 (en) A combination of therapeutic agents
TWI245756B (en) Improved process for the preparation of 1,3-substituted indenes
AU1146401A (en) Use of 5ht-1a-serotonine receptor agonists for treating genetic or functional rhythm disorders in the respiratory system
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine